Replies to post #220226 on Biotech Values

[DewDiligence]

MRK—US Keytruda sales by indication: 60-65% NSCLC; 15% melanoma; 5% bladder; 5% MSI-high; 10-15% other. (Source: MRK’s 2Q18 CC.)

MRK 2Q18 PR:
https://finance.yahoo.com/news/merck-announces-second-quarter-2018-104500377.html